Quest PharmaTech Inc.
QPTFF
$0.0133
-$0.0017-11.33%
OTC PK
| 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | 01/31/2024 | |
|---|---|---|---|---|---|
| Net Income | 42.87% | 96.70% | 95.47% | 94.12% | 95.37% |
| Total Depreciation and Amortization | -- | -100.00% | -100.00% | -42.42% | -79.05% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -43.36% | -97.41% | -96.27% | -94.81% | -96.25% |
| Change in Net Operating Assets | -165.98% | -168.56% | 130.51% | 94.46% | 204.06% |
| Cash from Operations | -48.09% | -22.71% | 12.84% | 20.54% | 40.03% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 90.00% |
| Total Debt Issued | -- | -100.00% | -100.00% | -- | -60.00% |
| Total Debt Repaid | -- | 100.00% | 100.00% | 100.00% | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | 660.78% | 660.78% | 660.78% | 660.78% |
| Cash from Financing | -- | 635.07% | 503.81% | 1,097.12% | -4.07% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -247.86% | 125.20% | 153.63% | 160.69% | 163.25% |